These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 5167213)

  • 1. Influence of culture media on the antistaphylococcal activity of fosfomycin.
    Hoeprich PD; Finn PD
    Appl Microbiol; 1971 Nov; 22(5):781-3. PubMed ID: 5167213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of fosfomycin activity in Mueller-Hinton media and in tissues.
    Dette GA; Knothe H; Schönenbach B; Plage G
    J Antimicrob Chemother; 1983 Jun; 11(6):517-24. PubMed ID: 6885678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro investigations with fosfomycin on Mueller-Hinton agar with and without glucose-6-phosphate.
    Grimm H
    Infection; 1979; 7(5):256-9. PubMed ID: 389806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of phosphonic acid analogues of glycerol-3-phosphate on the growth of Escherichia coli.
    Shopsis CS; Engel R; Tropp BE
    J Bacteriol; 1972 Oct; 112(1):408-12. PubMed ID: 4562403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of culture media on the fosfomycin sensitivity of six Serratia strains and their resistant mutants.
    Drugeon HB; Courtieu AL
    Chemotherapy; 1982; 28(5):345-50. PubMed ID: 7140421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel two-component regulatory system, HptRS, the regulator for the hexose phosphate transport system in Staphylococcus aureus.
    Park JY; Kim JW; Moon BY; Lee J; Fortin YJ; Austin FW; Yang SJ; Seo KS
    Infect Immun; 2015 Apr; 83(4):1620-8. PubMed ID: 25644013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibacterial activities of fosfomycin against several fresh clinical isolates--comparison of the test methods for antibacterial activity].
    Hara T; Araake M; Watabe H
    Jpn J Antibiot; 2002 Dec; 55(6):844-54. PubMed ID: 12621737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conditions influencing the activity of fosfomycin in vitro (author's transl)].
    Haag R; Vömel W
    Immun Infekt; 1979 Dec; 7(6):202-9. PubMed ID: 396228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of glucose-6-phosphate and inorganic phosphate on the resistance of Klebsiella species and E. coli towards fosfomycin (author's transl)].
    Hirschl A; Rotter M
    Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):461-9. PubMed ID: 396739
    [No Abstract]   [Full Text] [Related]  

  • 10. [Susceptibility testing with fosfomycin in an agar diffusion test on Mueller-Hinton agar].
    Grimm H; Haag R
    Immun Infekt; 1982 Jul; 10(4):159-63. PubMed ID: 6813250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved susceptibility test based on Amberlite reveals the potential antilisterial activity of fosfomycin in vitro.
    Han L; Lei J; Han S; He L; Ma C; Yu P; Wu X; Xu J
    Can J Microbiol; 2013 Apr; 59(4):252-9. PubMed ID: 23586749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antibacterial activity of FR-31564, a phosphonic acid antimicrobial agent.
    Neu HC; Kamimura T
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1013-23. PubMed ID: 7271270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of the culture medium in the sensitivity of Gram-negative stocks and their resistant mutants to fosfomycin. The influence of glucose-6-phosphate].
    Drugeon H; Courtieu AL
    Minerva Med; 1978 Dec; 69(59):4055-60. PubMed ID: 105326
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of phosphonomycin, a new antibacterial antibiotic.
    Raab W; Windisch J
    Pathol Microbiol (Basel); 1971; 37(5):368-75. PubMed ID: 4108480
    [No Abstract]   [Full Text] [Related]  

  • 15. [Topical use of phosphonomycin].
    Raab W; Windisch J
    Arch Dermatol Forsch; 1973 Jan; 246(1):27-34. PubMed ID: 4120915
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fosfomycin, a new antibiotic: in vitro activity compared with mezlocillin, cefuroxime and gentamicin].
    Lindenschmidt EG; Schassan HH
    Immun Infekt; 1980; 8(4):121-6. PubMed ID: 6453080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antistaphylococcal activity of cefdinir, a new oral third-generation cephalosporin, alone and in combination with other antibiotics, at supra- and sub-MIC levels.
    Marchese A; Saverino D; Debbia EA; Pesce A; Schito GC
    J Antimicrob Chemother; 1995 Jan; 35(1):53-66. PubMed ID: 7768782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the activity of the trometamol salt of fosfomycin.
    Greenwood D; Jones A; Eley A
    Eur J Clin Microbiol; 1986 Feb; 5(1):29-34. PubMed ID: 3084242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro development of resistance to fosfomycin.
    Dulaney EL; Ruby CL
    J Antibiot (Tokyo); 1977 Mar; 30(3):252-61. PubMed ID: 324957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigations on the antibacterial activity of fosfomycin on DST-agar (author's transl)].
    Hirschl A; Rotter M; Maruna H
    Zentralbl Bakteriol Orig A; 1978 Dec; 242(4):537-46. PubMed ID: 749420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.